Effective and safe proton pump inhibitor therapy in acid-related diseases–a position paper addressing benefits and potential harms of acid suppression

C Scarpignato, L Gatta, A Zullo, C Blandizzi… - BMC medicine, 2016 - Springer
Background The introduction of proton pump inhibitors (PPIs) into clinical practice has
revolutionized the management of acid-related diseases. Studies in primary care and …

The role of microbiome in insomnia, circadian disturbance and depression

Y Li, Y Hao, F Fan, B Zhang - Frontiers in psychiatry, 2018 - frontiersin.org
Good sleep and mood are important for health and for kee** active. Numerous studies
have suggested that the incidence of insomnia and depressive disorder are linked to …

Randomized trial of medical versus surgical treatment for refractory heartburn

SJ Spechler, JG Hunter, KM Jones, R Lee… - … England Journal of …, 2019 - Mass Medical Soc
Background Heartburn that persists despite proton-pump inhibitor (PPI) treatment is a
frequent clinical problem with multiple potential causes. Treatments for PPI-refractory …

Management of functional communication, swallowing, cough and related disorders: consensus recommendations for speech and language therapy

J Baker, C Barnett, L Cavalli, M Dietrich… - Journal of Neurology …, 2021 - jnnp.bmj.com
Communication problems (eg, dysphonia, dysfluency and language and articulation
disorders), swallowing disorders (dysphagia and globus), cough and upper airway …

Prevalence of oropharyngeal dysphagia in geriatric patients and real-life associations with diseases and drugs

U Wolf, S Eckert, G Walter, A Wienke, S Bartel… - Scientific reports, 2021 - nature.com
Risk factors for oropharyngeal dysphagia (OD) in elderly patients are mainly central nervous
system (CNS) and structural organic diseases or presbyphagia. We analysed the OD …

Association between psychosocial disorders and gastroesophageal reflux disease: a systematic review and meta-analysis

M He, Q Wang, D Yao, J Li… - Journal of …, 2022 - pmc.ncbi.nlm.nih.gov
Background/Aims The incidence of gastroesophageal reflux disease (GERD) is increasing
annually. Studies have suggested that psychosocial disorders may be linked to the …

Refractory gastroesophageal reflux disease: a management update

F Rettura, F Bronzini, M Campigotto, C Lambiase… - Frontiers in …, 2021 - frontiersin.org
Gastroesophageal reflux disease (GERD) is one of the most frequent gastrointestinal
disorders. Proton pump inhibitors (PPIs) are effective in healing lesions and improving …

Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non‐erosive reflux disease–efficacy of Esoxx, a hyaluronic acid …

V Savarino, F Pace, C Scarpignato… - Alimentary …, 2017 - Wiley Online Library
Background Several studies have shown that patients with non‐erosive reflux disease
(NERD) are less responsive to proton pump inhibitors (PPI s) than those with erosive …

Клинические рекомендации Российской гастроэнтерологической ассоциации и ассоциации колопроктологов России по диагностике и лечению болезни …

Р Статья - Колопроктология, 2017 - ruproctology.com
1.1. Термины и определение Болезнь Крона (БК)–хроническое, рецидивирующее
заболевание желудочно-кишечного тракта неясной этиологии, характеризующееся …

Management of refractory typical GERD symptoms

E Scarpellini, D Ang, A Pauwels, A De Santis… - Nature Reviews …, 2016 - nature.com
The management of patients with refractory GERD (rGERD) is a major clinical challenge for
gastroenterologists. In up to 30% of patients with typical GERD symptoms (heartburn and/or …